共 50 条
- [1] Omalizumab (Xolair):: An anti-IgE antibody for asthma [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1163): : 67 - 68
- [2] Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2020, 50 (10): : 1196 - 1199
- [7] Omalizumab: Anti-IgE Therapy in Allergy [J]. Current Allergy and Asthma Reports, 2011, 11 : 101 - 106
- [8] Omalizumab: Beyond anti-IgE properties [J]. REVUE DES MALADIES RESPIRATOIRES, 2017, 34 (02) : 121 - 133